CD52 and OXPHOS - potential targets in ibrutinib treated mantle cell lymphoma
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
We performed a RNA-seq analysis of an ibrutinib-sensitive mantle cell lymphoma cell line treated with ibrutinib for up to 4 d to study transcriptomic adaptations to the BTK inhibitor in surviving cells. Differential gene expression analysis across ibrutinib treatment in the ibrutinib-sensitive mantle cell lymphoma cell line REC-1.
创建时间：
2023-01-13
